TABLE 4.
Analysis of metabolic pathways in serum based on potential biomarkers
| No | Pathway Name | Match Status | Raw p | -log (p) | Impact |
|---|---|---|---|---|---|
| 1 | Glycerophospholipid metabolism | 2/36 | 0.021 | 1.678 | 0.199 |
| 2 | Pyrimidine metabolism | 2/39 | 0.024 | 1.612 | 0.097 |
| 3 | Linoleic acid metabolism | 1/5 | 0.032 | 1.496 | 0.000 |
| 4 | alpha-Linolenic acid metabolism | 1/13 | 0.081 | 1.092 | 0.000 |
| 5 | Glycosylphosphatidylinositol (GPI) -anchor biosynthesis | 1/14 | 0.087 | 1.061 | 0.004 |
| 6 | Arachidonic acid metabolism | 1/36 | 0.210 | 0.678 | 0.000 |
Control group, model group and Ganlong capsule treatment group (n = 6). Model group compared with normal control group, *p < 0.05, **p < 0.01. Ganlong capsule group compared with model group, # P < 0.05, ## P < 0.01.